Agenus Inc (AGEN)
4.225
-0.16
(-3.76%)
USD |
NASDAQ |
Oct 31, 16:00
4.225
0.00 (0.00%)
After-Hours: 20:00
Agenus Total Liabilities (Quarterly): 513.25M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 513.25M |
March 31, 2024 | 446.88M |
December 31, 2023 | 462.30M |
September 30, 2023 | 450.76M |
June 30, 2023 | 460.35M |
March 31, 2023 | 465.96M |
December 31, 2022 | 468.46M |
September 30, 2022 | 440.86M |
June 30, 2022 | 442.54M |
March 31, 2022 | 413.66M |
December 31, 2021 | 418.05M |
September 30, 2021 | 402.09M |
June 30, 2021 | 448.05M |
March 31, 2021 | 432.86M |
December 31, 2020 | 426.01M |
September 30, 2020 | 410.81M |
June 30, 2020 | 411.75M |
March 31, 2020 | 382.56M |
December 31, 2019 | 386.67M |
September 30, 2019 | 379.68M |
June 30, 2019 | 368.32M |
March 31, 2019 | 365.22M |
December 31, 2018 | 310.95M |
September 30, 2018 | 261.87M |
June 30, 2018 | 245.02M |
Date | Value |
---|---|
March 31, 2018 | 244.05M |
December 31, 2017 | 214.22M |
September 30, 2017 | 200.86M |
June 30, 2017 | 193.97M |
March 31, 2017 | 194.36M |
December 31, 2016 | 196.11M |
September 30, 2016 | 195.88M |
June 30, 2016 | 179.58M |
March 31, 2016 | 176.69M |
December 31, 2015 | 171.50M |
September 30, 2015 | 165.63M |
June 30, 2015 | 92.92M |
March 31, 2015 | 71.07M |
December 31, 2014 | 51.51M |
September 30, 2014 | 38.76M |
June 30, 2014 | 42.56M |
March 31, 2014 | 45.02M |
December 31, 2013 | 39.32M |
September 30, 2013 | 40.55M |
June 30, 2013 | 38.63M |
March 31, 2013 | 47.82M |
December 31, 2012 | 46.69M |
September 30, 2012 | 45.38M |
June 30, 2012 | 44.63M |
March 31, 2012 | 43.84M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
382.56M
Minimum
Mar 2020
513.25M
Maximum
Jun 2024
435.99M
Average
440.86M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 77.58B |
AIM ImmunoTech Inc | 9.613M |
Perspective Therapeutics Inc | 44.92M |
Protalix BioTherapeutics Inc | 62.96M |
Armata Pharmaceuticals Inc | 154.41M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 292.42M |
Shareholders Equity (Quarterly) | -241.31M |
Debt to Equity Ratio | -0.0556 |
Current Ratio | 0.3695 |
Net Debt Paydown Yield | 0.01% |